Amlodipine, Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 65862-838

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan And Hydrochlorothiazide (NDC 65862-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Amlovalhctz Fig1)

A bar chart comparing the effects of different drug combinations on diastolic and systolic blood pressure. The chart shows four groups: Hydrochlorothiazide/Amlodipine 25 mg/10 mg, Valsartan/Hydrochlorothiazide 320 mg/25 mg, Amlodipine/Valsartan 10 mg/320 mg, and Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/320 mg/25 mg. Each group has corresponding bars indicating reductions in diastolic and systolic blood pressure values.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg/25 mg (30 Tablets Bottle))

Packaging label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP 10 mg/320 mg/25 mg, film-coated tablets in a 30 count package. The label displays dosage information, storage instructions, and is distributed by Aurobindo Pharma USA, Inc. with product origin made in India.*

FDA Label Image

Figure2 (Amlovalhctz Fig2)

A line graph showing mean sitting diastolic blood pressure (mmHg) over an 8-week period for four treatments: Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/320 mg/25 mg, Amlodipine/Valsartan 10 mg/320 mg, Valsartan/Hydrochlorothiazide 320 mg/25 mg, and Hydrochlorothiazide/Amlodipine 25 mg/10 mg. The graph illustrates changes in diastolic blood pressure from week 0 to week 8 for each treatment group.*

FDA Label Image

Figure3 (Amlovalhctz Fig3)

A line chart displaying mean sitting systolic blood pressure (SBP) in mmHg over an 8-week period for four different treatment groups involving combinations of amlodipine, valsartan, and hydrochlorothiazide at various dosages. The x-axis shows weeks from 0 to 8, and the y-axis shows mean sitting SBP values ranging approximately from 120 to 180 mmHg.*

FDA Label Image

Figure4 (Amlovalhctz Fig4)

A line graph depicting mean ambulatory diastolic blood pressure (DBP) in mmHg over 24 hours after dosing. The chart compares four treatments: Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/320 mg/25 mg, Amlodipine/Valsartan 10 mg/320 mg, Valsartan/Hydrochlorothiazide 320 mg/25 mg, and Hydrochlorothiazide/Amlodipine 25 mg/10 mg. The x-axis shows hours after dosing, and the y-axis shows DBP values from 60 to 100 mmHg.*

FDA Label Image

Figure5 (Amlovalhctz Fig5)

A line graph showing mean ambulatory systolic blood pressure (SBP) in mmHg plotted against hours after dosing (0 to 24 hours). The graph compares four treatments: Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/320 mg/25 mg, Amlodipine/Valsartan 10 mg/320 mg, Valsartan/Hydrochlorothiazide 320 mg/25 mg, and Hydrochlorothiazide/Amlodipine 25 mg/10 mg, each represented by distinct line symbols as indicated in the legend below the graph.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg/12.5 mg (30 Tablets Bottle))

A pharmaceutical label for Amlodipine, Valsartan, and Hydrochlorothiazide Tablets USP with strength 5 mg/160 mg/12.5 mg. It is a film-coated oral tablet, packaged in a quantity of 30 tablets. The label includes dosing information, storage instructions, and distributor details for Aurobindo Pharma USA, Inc. The product is marked Rx only and is made in India.*

FDA Label Image

Package Label-principal Display Panel -10 mg/160 mg/12.5 mg (30 Tablets Bottle) (Amlovalhctz Fig7)

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP 10 mg/160 mg/12.5 mg, film-coated tablets, packaged in a bottle of 30 tablets. Label shows dosage strengths, NDC 65862-836-30, distributed by Aurobindo Pharma USA, Inc., with storage instructions and warnings to keep out of children's reach. Made in India.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg/25 mg (30 Tablets Bottle))

Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP 5 mg/160 mg/25 mg film-coated tablets in a package of 30 tablets. The label states the active ingredient strengths and storage instructions, distributed by Aurobindo Pharma USA, Inc., with a barcode and manufacturing origin as India.*

FDA Label Image

Package Label-principal Display Panel (10 mg/160 mg/25 mg (30 Tablets Bottle))

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP, 10 mg/160 mg/25 mg, film-coated tablets. The label shows a package of 30 tablets by Aurobindo Pharma Limited. It includes dosage information and storage instructions, as well as distributor details for Aurobindo Pharma USA, Inc. The label features a barcode and the NDC 65862-837-30.*

FDA Label Image

Amlodipine Molecular Structure (Amlovalhctz Str1)

Chemical structure diagram showing molecular components, including a chlorine-substituted aromatic ring, ethyl ester groups, and a sulfonic acid moiety. This structure likely represents active pharmaceutical ingredients associated with the product containing Amlodipine, Valsartan, and Hydrochlorothiazide.*

FDA Label Image

Valsartan Molecular Structure (Amlovalhctz Str2)

Chemical structure of Amlodipine, Valsartan and Hydrochlorothiazide. The diagram shows the molecular arrangement of atoms typical for this combination drug used in oral tablet form by Aurobindo Pharma Limited.*

FDA Label Image

Hydrochlorothiazide Molecular Structure (Amlovalhctz Str3)

Chemical structure diagram showing the molecular structure of the active ingredient from the product labeled as Amlodipine, Valsartan and Hydrochlorothiazide. The structure depicts atoms and bonds characteristic of the compound, including chlorine and sulfur groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.